# Hologic, Inc. – Consensus ‘buy’ rating and 14.5% Upside Potential

- Link: https://www.directorstalkinterviews.com/hologic-inc.consensus-buy-rating-and-14.5-upside-potential/4121145936
- Published: 2024-03-04T13:31:56+00:00
- Author: Charlotte Edwards

**Hologic, Inc.** with ticker code (HOLX) now have 14 market analysts covering the
stock. The analyst consensus now points to a rating of ‘buy’. The target price High/
Low ranges between $95.00 and $76.00 suggesting an average Analsyt target price 
of $84.50. Given that the stocks previous close was at $73.80 this is indicating
there is a potential upside of 14.5%. It’s also worth noting that there is a 50 
day moving average of $73.28 and the 200 moving average now moves to $74.02. The
market capitalization for the company is 17.29B. The stock price for the company
is currently is currently $73.65 USD

 The potential market cap would be $19,794,539,229 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 34.91, revenue per share of $16.23
and a 6.49% return on assets.

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products,
medical imaging systems, and surgical products focused on women’s health and well-
being through early detection and treatment. The Company operates through four segments:
Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics segment
offers a range of diagnostics products, such as ThinPrep cytology system, and the
Rapid Fetal Fibronectin Test. Its Breast Health segment offers a portfolio of solutions
for breast cancer care, primarily in the areas of radiology, breast surgery, pathology
and treatment. The GYN Surgical segment offers a range of products, such as NovaSure
Endometrial Ablation System, MyoSure Hysteroscopic Tissue Removal System and Fluent
Fluid Management system as well as its Acessa ProVu laparoscopic radiofrequency 
ablation system. The Skeletal Health segment offers products such as the Horizon
DXA, a dual energy x-ray system, and the Fluoroscan Insight FD mini C-arm.

Share on:
